dC (Bz) (5-Me) CPG
CPG used to incorporate a 5-methyl-modified deoxycytidine into the 3' end of an oligonucleotide.
CPG used to incorporate a 5-methyl-modified deoxycytidine into the 3' end of an oligonucleotide.
CPG column used to incorporate a 5-methyl-modified deoxycytidine into the 3' end of an oligonucleotide.
CPG synthesis column for incorporation of unmodified dC at 3' end of an oligonucleotide.
CPG synthesis column for incorporation of unmodified dC at 3' end of an oligonucleotide.
CPG column for incorporation of an (otherwise unmodified) reverse (5' to 3') dC nucleobase at the 3' end of an oligonucleotide.
CPG synthesis column for incorporation of unmodified dC at 3' end of an oligonucleotide.
CPG column for the incorporation of an amino function at the 3' end of an oligonucleotide.
CPG used to 3'-label an oligonucleotide with the dabcyl quencher moiety.
Dideoxynucleoside CPG used in nuclease blocking.
Europe, Middle East, and Africa | |
---|---|
UK | +44 1992 470 757 |
Germany | +49 30 5304 2200 |
North America, Latin America | |
Wisconsin, USA | +1 888 575 9695 |
Asia Pacific | |
China | +8621-22509000 |
Singapore | +65 6734 4800 |